Marsh & McLennan (MMC) just released a knockout earnings report, beating estimates with an EPS of $2.72, six cents above the ...

Warren Buffett, the oracle of Omaha, has let slip that Berkshire Hathaway might not outshine the market anymore. In a ...

Nebius, backed by Nvidia, is making waves in the AI data center arena. The company's ARR run rate grew 684% year over year to ...

Johnson & Johnson is making headlines with shifting analyst ratings and price target adjustments. Guggenheim raised its ...

Visa's earnings are coming, and volatility is in the air! A long straddle strategy could be your ticket to profit. Buy a call ...

Microsoft faces a severe cybersecurity test as its SharePoint platform suffers a widespread global cyber attack. The incident ...

Amazon has recalibrated its pricing approach in light of ongoing trade tariffs, hiking up the cost of everyday items like ...

Broadcom has skyrocketed 2,000% in a decade, crushing the S&P 500. This year alone, it's up 19%, boasting a $1.3 trillion ...

UnitedHealth faces headwinds after a 50% stock drop and PR crises. Investors are worried about transparency and ...

Analysts are all over Eli Lilly, and most suggest a "Moderate Buy." Sixteen analysts recommend buying, while three say "hold.

Exxon Mobil saw some shifting in investor sentiment recently. Easterly Investment Partners decreased its stake by 50.3% ...

Alphabet stands out as a top "Magnificent Seven" stock. It offers exposure to AI, cybersecurity, and autonomous ...